INTRODUCTION: Lactate is a key biomarker in the assessment of critically ill patients, particularly in cardiogenic shock and cardiac arrest. Hyperlactatemia may result from several mechanisms, including tissue hypoperfusion, adrenergic activation, alterations in cellular metabolism, and reduced lactate clearance. In cardiogenic shock, macro- and microcirculatory disturbances, venous congestion, and organ dysfunction impair tissue oxygenation and energy metabolism. In cardiac arrest, circulatory interruption causes systemic ischemia, followed by a reperfusion phase that may prolong metabolic disturbances even after the restoration of spontaneous circulation. METHODS: This was a retrospective, single-center, observational cohort study conducted at the Cardiac Intensive Care Unit of the University Hospital of Padua. Adult patients admitted between 2016 and 2026 for cardiogenic shock or in-hospital or out-of-hospital cardiac arrest with return of spontaneous circulation were included. In the primary analysis, patients were divided into two groups: cardiogenic shock without cardiac arrest and patients resuscitated from cardiac arrest. Secondary analyses further classified patients into three phenotypes, including those with cardiogenic shock associated with cardiac arrest. The primary endpoint was all-cause in-hospital mortality. The main objective was to assess whether the association between admission lactate levels and mortality differed between the two groups. Secondary objectives included comparing lactate levels, evaluating their relationship with mortality and discriminatory performance, assessing lactate trends during the first 48 hours, and investigating differences according to presenting rhythm and cardiac arrest etiology. RESULTS: A total of 604 patients were included, of whom 288 had cardiogenic shock without cardiac arrest and 316 were resuscitated from cardiac arrest; among the latter, 151 also presented with cardiogenic shock. Admission lactate levels were higher in patients with cardiac arrest than in those with cardiogenic shock without cardiac arrest (median 5.0 vs. 3.8 mmol/L), with the highest levels observed in the cardiogenic shock associated with cardiac arrest phenotype (6.3 mmol/L). Admission lactate was associated with in-hospital mortality in both groups, with no significant difference in the primary analysis. Among patients with cardiogenic shock, the prognostic value of lactate was similar regardless of the presence of cardiac arrest. Conversely, in patients with cardiac arrest without shock, the association with mortality was stronger and discriminatory performance was higher than in the shock phenotypes. Among patients with cardiogenic shock, mortality remained high even at relatively low lactate concentrations, whereas in patients with cardiac arrest without shock, lactate levels below 5 mmol/L identified a subgroup with a more favorable prognosis. CONCLUSIONS: Admission lactate is associated with in-hospital mortality across all clinical phenotypes, although its prognostic significance varies according to the clinical context. In patients with cardiogenic shock, its prognostic value is similar regardless of the presence of cardiac arrest, whereas in post-cardiac arrest patients without shock, lactate shows greater discriminatory performance. These findings suggest that post-resuscitation hyperlactatemia and hyperlactatemia associated with persistent shock may reflect different pathophysiological conditions. Therefore, lactate should be interpreted alongside other clinical and hemodynamic parameters to ensure accurate prognostic assessment. Further prospective multicenter studies are needed to confirm these findings.
INTRODUZIONE: il lattato rappresenta un biomarcatore fondamentale nella valutazione del paziente critico, in particolare nello shock cardiogeno e nell’arresto cardiaco. L’iperlattatemia può derivare da diversi meccanismi, tra cui ipoperfusione tissutale, attivazione adrenergica, alterazioni del metabolismo cellulare e ridotta clearance. Nello shock cardiogeno, le alterazioni del macro e microcircolo, la congestione venosa e la disfunzione d’organo compromettono l’ossigenazione tissutale e il metabolismo energetico. Nell’arresto cardiaco, l’interruzione della circolazione determina ischemia sistemica, seguita da una fase di riperfusione che può prolungare le alterazioni metaboliche anche dopo il ripristino della circolazione spontanea. METODI: è stato condotto uno studio di coorte osservazionale, retrospettivo e monocentrico presso l’Unità di Terapia Intensiva Cardiologica dell’Azienda Ospedale–Università di Padova. Sono stati inclusi pazienti adulti ricoverati tra il 2016 e il 2026 per shock cardiogeno o arresto cardiaco. Nell’analisi primaria i pazienti sono stati suddivisi in due gruppi: shock cardiogeno senza arresto cardiaco e pazienti rianimati da arresto cardiaco. Le analisi secondarie hanno distinto tre fenotipi, considerando anche i pazienti con shock associato e successivo arresto cardiaco. L’esito primario era la mortalità intraospedaliera per qualsiasi causa. L’obiettivo principale era valutare se l’associazione tra lattato all’ingresso e mortalità differisse tra i due gruppi. Gli obiettivi secondari comprendevano il confronto dei livelli di lattato, la valutazione della relazione con la mortalità, della capacità discriminativa e dell’andamento nelle prime 48 ore, nonché l’analisi delle differenze in base al ritmo di presentazione e all’eziologia dell’arresto. RISULTATI: sono stati inclusi 604 pazienti, di cui 288 con shock cardiogeno senza arresto e 316 rianimati da arresto cardiaco; tra questi ultimi, 151 presentavano anche shock cardiogeno. Il lattato all’ingresso era più elevato nei pazienti con arresto rispetto a quelli con shock senza arresto (mediana 5,0 vs 3,8 mmol/L), con i valori più alti nel fenotipo shock associato ad arresto (6,3 mmol/L). Il lattato si associava alla mortalità intraospedaliera in entrambi i gruppi, senza differenze significative nell’analisi primaria. Tra i pazienti con shock cardiogeno, il valore prognostico del lattato era simile indipendentemente dalla presenza di arresto. Al contrario, nei pazienti con arresto senza shock, l’associazione con la mortalità era più marcata e la capacità discriminativa maggiore rispetto ai fenotipi caratterizzati da shock. Nei pazienti con shock, la mortalità rimaneva elevata anche in presenza di concentrazioni relativamente basse di lattato, mentre nell’arresto senza shock valori inferiori a 5 mmol/L identificavano un sottogruppo a prognosi più favorevole. CONCLUSIONI: Il lattato all’ingresso è associato alla mortalità intraospedaliera in tutti i fenotipi considerati, ma il suo significato prognostico varia in funzione del contesto clinico. Nei pazienti con shock cardiogeno, il valore prognostico è simile indipendentemente dalla presenza di arresto, mentre nei pazienti post-arresto senza shock il lattato presenta una maggiore capacità discriminativa. Questi risultati suggeriscono che l’iperlattatemia post-rianimatoria e quella associata a shock persistente riflettano condizioni fisiopatologiche differenti. Il lattato deve pertanto essere integrato con gli altri parametri clinici ed emodinamici per una corretta stratificazione prognostica. Sono necessari studi prospettici multicentrici per confermare tali osservazioni.
Il valore prognostico del lattato nello Shock Cardiogeno e nell'Arresto Cardiaco: due popolazioni a confronto
DAL BORGO, LORENZO
2024/2025
Abstract
INTRODUCTION: Lactate is a key biomarker in the assessment of critically ill patients, particularly in cardiogenic shock and cardiac arrest. Hyperlactatemia may result from several mechanisms, including tissue hypoperfusion, adrenergic activation, alterations in cellular metabolism, and reduced lactate clearance. In cardiogenic shock, macro- and microcirculatory disturbances, venous congestion, and organ dysfunction impair tissue oxygenation and energy metabolism. In cardiac arrest, circulatory interruption causes systemic ischemia, followed by a reperfusion phase that may prolong metabolic disturbances even after the restoration of spontaneous circulation. METHODS: This was a retrospective, single-center, observational cohort study conducted at the Cardiac Intensive Care Unit of the University Hospital of Padua. Adult patients admitted between 2016 and 2026 for cardiogenic shock or in-hospital or out-of-hospital cardiac arrest with return of spontaneous circulation were included. In the primary analysis, patients were divided into two groups: cardiogenic shock without cardiac arrest and patients resuscitated from cardiac arrest. Secondary analyses further classified patients into three phenotypes, including those with cardiogenic shock associated with cardiac arrest. The primary endpoint was all-cause in-hospital mortality. The main objective was to assess whether the association between admission lactate levels and mortality differed between the two groups. Secondary objectives included comparing lactate levels, evaluating their relationship with mortality and discriminatory performance, assessing lactate trends during the first 48 hours, and investigating differences according to presenting rhythm and cardiac arrest etiology. RESULTS: A total of 604 patients were included, of whom 288 had cardiogenic shock without cardiac arrest and 316 were resuscitated from cardiac arrest; among the latter, 151 also presented with cardiogenic shock. Admission lactate levels were higher in patients with cardiac arrest than in those with cardiogenic shock without cardiac arrest (median 5.0 vs. 3.8 mmol/L), with the highest levels observed in the cardiogenic shock associated with cardiac arrest phenotype (6.3 mmol/L). Admission lactate was associated with in-hospital mortality in both groups, with no significant difference in the primary analysis. Among patients with cardiogenic shock, the prognostic value of lactate was similar regardless of the presence of cardiac arrest. Conversely, in patients with cardiac arrest without shock, the association with mortality was stronger and discriminatory performance was higher than in the shock phenotypes. Among patients with cardiogenic shock, mortality remained high even at relatively low lactate concentrations, whereas in patients with cardiac arrest without shock, lactate levels below 5 mmol/L identified a subgroup with a more favorable prognosis. CONCLUSIONS: Admission lactate is associated with in-hospital mortality across all clinical phenotypes, although its prognostic significance varies according to the clinical context. In patients with cardiogenic shock, its prognostic value is similar regardless of the presence of cardiac arrest, whereas in post-cardiac arrest patients without shock, lactate shows greater discriminatory performance. These findings suggest that post-resuscitation hyperlactatemia and hyperlactatemia associated with persistent shock may reflect different pathophysiological conditions. Therefore, lactate should be interpreted alongside other clinical and hemodynamic parameters to ensure accurate prognostic assessment. Further prospective multicenter studies are needed to confirm these findings.| File | Dimensione | Formato | |
|---|---|---|---|
|
DalBorgo_Lorenzo.pdf
Accesso riservato
Dimensione
3.2 MB
Formato
Adobe PDF
|
3.2 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/120694